Sepsis and the systemic inflammatory response syndrome: Neuromuscular manifestations

Critical Care Medicine

Volumn 24, Issue 8, 1996, Pages 1408-1416

  Bolton, Charles F ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

critical illness; myopathy; neurologic emergencies; neuromuscular blocking agents; neuromuscular disease; polyneuropathy; sepsis; steroids; systemic inflammatory response syndrome

Indexed keywords

CORTICOSTEROID; CREATINE KINASE; NEUROMUSCULAR BLOCKING AGENT; PANCURONIUM BROMIDE; VECURONIUM;

HUMAN; INFLAMMATION; INTENSIVE CARE; MEDICAL LITERATURE; MOTOR NEUROPATHY; MUSCLE BIOPSY; MYOPATHY; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYNEUROPATHY; PRIORITY JOURNAL; PUBLICATION; REVIEW; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0029786545     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199608000-00022     Document Type: Review

References (82)

1. Critchley M (Editor-in-Chief): Butterworths Medical Dictionary. Second Edition. Boston, Butterworths, 1978, p 1415
2. Lowry SF: Sepsis and its complications: Clinical definitions and therapeutic prospects. Crit Care Med 1994; 22:S1-S2
3. Bone RC: Sepsis syndrome. New insights into its pathogenesis and treatment. Intensive Care World 1992; 4:50-59
4. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee: American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-874
5. Glauser MP, Zanetti G, Baumgartner J-D, et al: Septic shock: Pathogenesis. Lancet 1991; 338:732-736
6. Cowley HC, Heney D, Gearing AJH, et al: Increased circulating adhesion molecule concentrations in patients with the systemic inflammatory response syndrome: A prospective cohort study. Crit Care Med 1994; 22:651-657
7. Palmer RMJ, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-526
8. Dhainaut J-FA, Tenaillon A, Le Tulzo Y, et al: Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: A randomized, double-blind, placebo-controlled, multicenter clinical trial. Crit Care Med 1994; 22:1720-1728
9. Spies CD, Reinhart K, Witt I, et al: Influence of N-acetyl-cysteine on indirect indicators of tissue oxygenation in septic shock patients: Results from a prospective, randomized, double-blind study. Crit Care Med 1994; 22:1738-1746
10. Bolton CF: Neuromuscular complications of sepsis. Intensive Care Med 1993; 19:S58-S63
11. Bolton CF: Critical illness polyneuropathy. In: Peripheral Nerve Disorders II. Thomas PK, Asbury A (Eds). Oxford, UK, Butterworth-Heinemann, 1995, pp 262-270
12. Bolton CF: Electrophysiologic studies of critically ill patients. Muscle Nerve 1987; 10:129-135
13. Bolton CF: Muscle weakness and difficulty in weaning from the ventilator in the critical care unit. Chest 1994; 106:1-2
14. Osier W: The Principles and Practice of Medicine. New York, D Appleton, 1892, pp 114-118
15. Mertens HG: Die disseminierte neuropathie nach koma. Nervenarzt 1961; 32: 71-79
16. Erbsloh F, Abel M: Deficiency neuropathies. In: Handbook of Clinical Neurology. Chapter 23. Vinken J, Bruyn GW (Eds). Amsterdam, North Holland, 1989, pp 603-604
17. Henderson B, Koepke GH, Feller I: Peripheral polyneuropathy among patients with burns. Arch Phys Med Rehabil 1971; 52:149-151
18. Bischoff A, Meier C, Roth F: Gentamicin-neurotoxizitat (polyneuropathie-enzephalopathie). Schweiz Med Wochenschr 1977; 107:3-8
19. Bolton CF, Brown JD, Sibbald WJ: The electrophysiologic investigation of respiratory paralysis in critically ill patients. Abstr. Neurology 1983; 33:186
20. Bolton CF, Gilbert JJ, Hahn AF, et al: Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry 1984; 47:1223-1231
21. Bolton CF, Laverty DA, Brown JD, et al: Critically ill polyneuropathy: Electrophysiological studies and differentiation from Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 1986; 49: 563-573
22. Zochodne DW, Bolton CF, Wells GA, et al: Critical illness polyneuropathy: A complication of sepsis and multiple organ failure. Brain 1987; 110:819-842
23. Young GB, Bolton CF, Austin TW, et al: The encephalopathy associated with septic illness. Clin Invest Med 1990; 13:297-304
24. Jackson AC, Gilbert JJ, Young GB, Bolton CF: The encephalopathy of sepsis. Can J Neurol Sci 1985; 12: 303-307
25. Witt NJ, Zochodne DW, Bolton CF, et al: Peripheral nerve function in sepsis and multiple organ failure. Chest 1991; 99:176-184
26. Spitzer AR, Giancarlo T, Maher L, et al: Neuromuscular causes of prolonged ventilator dependency. Muscle Nerve 1992; 15:682-686
27. Zochodne DW, Bolton CF, Thompson RT, et al: Myopathy in critical illness. Abstr. Muscle Nerve 1986; 9:652
28. Roelofs RI, Cerra F, Bielka N, et al: Prolonged respiratory insufficiency due to acute motor neuropathy: A new syndrome. Abstr. Neurology 1983; 33:240
29. Couturier JC, Robert D, Monier P: Polynevrites compliquant des sejours prolonges en reanimation: A propos de 11 cas d'etiologie encore inconnue. Lyon Medicine 1984; 252:247-249
30. Barat M, Brochet P, Bital C, et al: Polyneuropathies au cours de sejours prolonges en reanimation. Rev Neurol (Paris) 1987; 143:823-831
31. Lycklama J, Nijeholt A, Troost J: Critical illness polyneuropathy. In: Handbook of Clinical Neurology. Matthews WB (Ed). New York, Elsevier Science Publishers BV, 1987, pp 129-135
32. Leijten FSS, de Weerd AW: Critical illness polyneuropathy: A review of the literature, definition and pathophysiology. Clin Neurol Neurosurg 1994; 96: 10-19
33. Wijdicks EF, Litchy WJ, Harrison BA, et al: The clinical spectrum of critical illness polyneuropathy. Mayo Clin Proc 1994; 69:955-959
34. Op de Coul AAW, Lambregts PCLA, Koeman J, et al: Neuromuscular complications in patients given Pavulon (pancuronium bromide) during artificial ventilation. Clin Neurol Neurosurg 1985; 87:17-22
35. Subramony SH, Carpenter DE, Raju S, et al: Myopathy and prolonged neuromuscular blockade after lung transplant. Crit Care Med 1991; 19:1580-1582
36. Rossiter A, Souney PF, McGowan S, et al: Pancuronium-induced prolonged neuromuscular blockade. Crit Care Med 1991; 12:1583-1587
37. Gooch JL, Suchyta MR, Balbierz JM: Prolonged paralysis after treatment with neuromuscular junction blocking agents. Crit Care Med 1991; 9:1125-1131
38. Kupfer Y, Namba T, Kaldawi E, et al: Prolonged weakness after long-term infusion of vecuronium-bromide. Ann Intern Med 1991; 117:484-486
39. Barohn RJ, Jackson CE, Rogers SJ, et al: Prolonged paralysis due to nondepolarizing neuromuscular blocking agents and corticosteroids. Muscle Nerve 1994; 17:647-654
40. Giostra E, Magistris MRi, Pizzolato G, et al: Neuromuscular disorders in intensive care unit patients treated with pancuronium bromide. Chest 1994; 106: 210-220
41. MacFarlene IA, Rosenthal FD: Severe myopathy after status asthmaticus. Lancet 1977; ii:615
42. Sher JH, Shafiq SA, Schutta HS: Acute myopathy with selective lysis of myosin filaments. Neurology 1979; 29:100-106
43. Lacomis D, Smith TW, Chad DA: Acute myopathy and neuropathy in status asthmaticus: Case report and literature review. Muscle Nerve 1993; 16: 84-90
44. Zochodne DW, Ramsay DA, Saly V, et al: Acute necrotizing myopathy of intensive care: Electrophysiological studies. Muscle Nerve 1994; 17:285-292
45. Bolton CF: Clinical neurophysiology of the respiratory system. AAEM Minimonograph #40. Muscle Nerve 1993; 16: 809-818
46. Ropper AH, Wijdicks EFM, Truax BT: Guillain-Barre Syndrome. Philadelphia, FA Davis, 1991, pp 175-225
47. Young GB, Bolton CF, Austin TW, et al: The electroencephalogram in sepsis-associated encephalopathy. J Clin Neurophysiol 1991; 9:145-152
48. Maher J, Rutledge F, Remtulla H, et al: Neurophysiological assessment of failure to wean from a ventilator. Abstr. Can J Neurol Sci 1993; 20:828
49. Maher J, Rutledge F, Remtulla H, et al: Neuromuscular disorders associated with failure to wean from the ventilator. Intensive Care Med 1995; 21: 737-743
50. Segredo V, Caldwell JE, Matthay MA, et al: Persistent paralysis in critically ill patients after long-term administration of vecuronium. N Engl JMed 1992; 327:524-528
51. Leijten FSS, Harinck-de Weerd JE, Poortvliet DCJ, et al: The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation. JAMA 1995; 274:1221-1225
52. Sheth RD, Pryse-Philips WEM: Post-ventilatory quadriplegia: Critical illness polyneuropathy in childhood. Abstr. Neurology 1994; 44:A169
53. Dimachkie M, Austin SG, Slopis JM, et al: Critical illness polyneuropathy in childhood. Abstr. J Child Neurol 1994; 9:207
54. Bolton CF: EMG in the paediatric critical care unit. In: Paediatric Electromyography. Jones HR, Bolton CF, Harper M (Eds). New York, Raven Press, 1996, pp 445-466
55. Op de Coul AAW, Verheul GAM, Leyten ACM, et al: Critical illness polyneuromyopathy after artificial respiration. Clin Neurol Neurosurg 1991; 93:27-33
56. Danon MJ, Carpenter S: Myopathy and thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment. Muscle Nerve 1991; 14:1131-1139
57. Douglass JA, Tuxen DV, Horne M, et al: Myopathy in severe asthma. Am Rev Respir Dis 1991; 146:517-519
58. Hirano M, Ott BR, Raps EC: Acute quadriplegic myopathy: Complication of treatment with steroids, nondepolarizing blocking agents, or both. Neurology 1992; 42:2082-2087
59. Sitwell LD, Weinshenker BG, Monpetit V, et al: Complete ophthalmoplegia as a complication of acute corticosteroid- and pancuronium-associated myopathy. Neurology 1991; 41:921-922
60. Karpati G, Carpenter S, Eisen AA: Experimental core-like lesions and nemaline rods: A correlative morphological and physiological study. Arch Neurol 1972; 27:247-266
61. Clowes GHA, George BC, Villee CA: Muscle proteolysis induced by a circulating peptide in patients with sepsis or trauma. N Engl J Med 1983; 308: 545-552
62. Ramsay DA, Zochodne DW, Robertson DM, et al: A syndrome of acute severe muscle necrosis in intensive care unit patients. J Neuropathol Exp Neurol 1993; 52:387-398
63. Penn AS: Myoglobinuria. In: Myology. Vol 2. Engel AG, Banker BQ (Eds). New York, McGraw-Hill, 1986, p 1792
64. Bolton CF, Young GB, Zochodne DW: Neurological changes during severe sepsis. In: Current Topics in Intensive Care. No. 1. Philadelphia, WB Saunders, 1994, pp 180-217
65. Pringle CE, Bolton CF, Ramsay DA, et al: Muscle biopsy in critical illness: Electrophysiological and morphological correlations. Abstr. Can J Neurol Sci 1992; 2:297
66. Tenckhoff HA, Boen FST, Jebsen RH, et al: Polyneuropathy in chronic renal insufficiency. JAMA 1965; 192:1121-1124
67. Bolton CF, Young GB: Neurological Complications of Renal Disease. Boston, Butterworths, 1990, p 79
68. Asbury AK: Neuropathies with renal failure, hepatic disorders, chronic respiratory insufficiency, and critical illness. In: Peripheral Neuropathy. Dyck PJ, Thomas PK (Eds). Philadelphia, WB Saunders, 1993, pp 1251-1265
69. Gorson KC, Ropper AH: Acute respiratory failure neuropathy: A variant of critical illness polyneuropathy. Crit Care Med 1993; 21:267-271
70. Amato AA, Barohn RJ, Sahenk Z, et al: Polyneuropathy complicating bone marrow and solid organ transplantation. Neurology 1993; 43:1513-1518
71. Helm PA, Johnson ER, Carlton AM: Peripheral neurological problems in the acute burn patient. Burns 1977; 3: 123-125
72. Marquez S, Turley JJE, Peters WJ: Neuropathy in burn patients. Brain 1993; 116:471-483
73. de Saint-Victor JF, Durand G, Le Gulluche Y, et al: Neuropathies du syndrome de sepsis avec defaillance mutlifiscerale chez les brules: 2 cas avec revue de la literature. Rev Neurol (Paris) 1994; 150:149-154
74. Wilmshurst PT, Treacher DF, Lantos PL, et al: Critical illness polyneuropathy following severe hyperpyrexia. Q J Med 1995; 88:351-355
75. Teitelbaum JS, Zatorre RJ, Carpenter S, et al: Neurologic sequelae of domoic acid intoxication due to the ingestion of contaminated mussels. N Engl J Med 1990; 322:1781-1787
76. Leijten FSS, de Weerd AW: Letter to the Editor. N Engl J Med 1990; 323:1631
77. Lange DJ: Neuromuscular diseases associated with HIV-1 infection. Muscle Nerve 1994; 17:16-30
78. Low PA, Tuck RR, Takeuchi M: Nerve microenvironment in diabetic neuropathy. In: Diabetic Neuropathy. Dyck PJ, Thomas PK, Asbury AK, et al (Eds). Philadelphia, WB Saunders, 1987, pp 268-277
79. Tracey KJ, Lowry SF, Beutler B, et al: Cachectin/tumor necrosis factor mediates human muscle denervation: Topical 31-P spectroscopy studies. Magn Reson Med 1988; 7:373-383
80. Fong Y: Cachectin/TNF or II-1a induces cachexia with redistribution of body proteins. Am J Physiol 1989; 256:659-665
81. Wernig A, Pecot-Dechavassine M, Stover H: Sprouting and regression of the nerve at the frog neuromuscular junction in normal conditions and after prolonged paralysis with curare. J Neurocytol 1980; 9:277-303
82. Al-Lozi MT, Pestronk A, Yee WC, et al: Rapidly evolving myopathy with myosin-deficient muscle fibers. Ann Neurol 1994; 35:273-279